Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phase I Clinical Study of Seneca Valley Virus (SVV-001),a Replication-Competent Picornavirus, in Advanced Solid Tumors with Neuroendocrine Features

8 Feb 2011

Abstract excerpt

PURPOSE: Seneca Valley Virus (SVV-001) is a novel naturally occurring replication-competent picornavirus with potent and selective tropism for neuroendocrine cancer cell types, including small cell lung cancer. We conducted a first-in-human, first-in-class phase I clinical trial of this agent in patients with cancers with neuroendocrine features, including small cell lung cancer. EXPERIMENTAL DESIGN: Clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Respiratory viral infections research
Share to Viral Infections and Immunology Research
Share to Viral Infections and Vectors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21304001
DOI: 10.1158/1078-0432.ccr-10-1706

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Phase I Clinical Study of Seneca Valley Virus (SVV-001),a Replication-Competent Picornavirus, in Advanced Solid Tumors with Neuroendocrine FeaturesPMID 21304001Read ↗

Oncolytic Seneca Valley Virus: past perspectives and future directionsSemantic proximity Read ↗

Senecavirus A as an Oncolytic Virus: Prospects, Challenges and Development DirectionsSemantic proximity Read ↗

First-in-man Study of Western Reserve Strain Oncolytic Vaccinia Virus: Safety, Systemic Spread, and Antitumor ActivitySemantic proximity Read ↗

Oncolytic vesicular stomatitis virus as a treatment for neuroendocrine tumors.Semantic proximity Read ↗

Complete genome sequence analysis of Seneca Valley virus-001, a novel oncolytic picornavirusSemantic proximity Read ↗

Treatment of Invasive Retinoblastoma in a Murine Model Using an Oncolytic PicornavirusSemantic proximity Read ↗

Intravenous administration of Reolysin, a live replication competent RNA virus is safe in patients with advanced solid tumors.Semantic proximity Read ↗

Parvovirus H1 selectively induces cytotoxic effects on human neuroblastoma cellsSemantic proximity Read ↗

Tumor Selectivity of Oncolytic Parvoviruses: From in vitro and Animal Models to Cancer PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.